Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › abaloparatide

abaloparatide

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of abaloparatide

3 trials tracked of abaloparatide: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 40 citations.

3Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 2 Other / NA 1
  1. Phase 3 Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Completed · 40 cited
  2. Phase 3 Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM) Completed
  3. N/A Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Network meta-analysis compares osteoporosis drugs for bone density in men
Diabetes & Endocrinology Meta-analysis
Network meta-analysis compares osteoporosis drugs for bone density in men Men's Osteoporosis Drugs Work Better on Spines Than Hips
This network meta-analysis of 4,409 men with primary osteoporosis compared six medications. It found significant improvements in bone minera…
• Abaloparatide and teriparatide boost spine bone density most • Helps men with weak bones avoid fractures • Not yet proven to prevent actua…
Frontiers May 8, 2026
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months
Diabetes & Endocrinology Meta-analysis
In male osteoporosis, anabolic therapies improved lumbar spine and hip BMD more than antiresorptives at 12 months Men Get Osteoporosis Too — and Now We Know Which Drugs Win
This Bayesian network meta-analysis evaluated antiresorptive and anabolic pharmacological interventions in men with osteoporosis.
A new analysis of 18 clinical trials finds that bone-building drugs may outperform bone-preserving drugs for men with osteoporosis, especial…
Frontiers Apr 10, 2026